Clinical trial Recruiting at 1 site Interventional Ages 30 to 85

Prevention in PD: a six-month lifestyle program for PD and RBD

Official title: PREVENTION-IN-PD - Development of a Multidomain Lifestyle Intervention Study for Prodromal and Clinical Parkinson's Disease

Run by University Hospital Schleswig-Holstein · NCT07297407 · Data updated 2026-11-12

This study tests whether a six-month, structured lifestyle program combining exercise, Mediterranean diet, sleep guidance, and cognitive training helps people with Parkinson’s disease or REM sleep behavior disorder stick to healthier habits.

Quick facts

Study typeInterventional
Ages30 Years to 85 Years
SexAll
Enrollment99 (estimated)
SponsorUniversity Hospital Schleswig-Holstein
Academic / other
Locations1 site (Kiel)
StatusRecruiting
StartedApril 1, 2026
Main results expectedSeptember 2027
Study endsJanuary 2028
Registry record updatedOctober 15, 2026
Trial IDNCT07297407 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 30 to 85 with either early-to-moderate PD (Hoehn and Yahr 1–2.5) or polysomnographically confirmed iRBD, who are willing to participate in group and online sessions.

Probably not a fit

Individuals with dementia, significant depression, major medical CNS diseases, or those planning medication changes in the next six months may be less likely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility trial investigates if a multimodal lifestyle program can support adherence to lifestyle changes in people with Parkinson’s disease (PD) and REM sleep behavior disorder (RBD) over six months. Participants engage in structured physical training, diet counseling, sleep optimization, and cognitive training, with psychoeducation and personalization to boost motivation. The study also looks for early signals of impact on symptoms, quality of life, and overall health. It is conducted in Germany with multiple collaborating centers and is powered to assess feasibility and potential benefits rather than definitive clinical outcomes.

Why it matters

Potential benefit: If successful, participants may experience better adherence to healthy lifestyle habits and potential improvements in quality of life and early symptom measures.

How similar studies have gone: Previous work suggests lifestyle interventions can influence health behaviors, but this exact six-month multimodal program in PD/RBD populations is being tested for feasibility and adherence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All participants: ability to perform informed consent; age 30-85
* RBD group: polysomnographic proven diagnosis of isolated REM sleep behavior disorder (iRBD)
* PD group: early to moderate disease (Hoehn \& Yahr stage 1-2.5), diagnosis according to the Movement Disorder Society diagnostic criteria for clinical Parkinson's Disease
* Agreement to participate in group sessions and online meetings

Exclusion Criteria:

* dementia (Mini Mental Score, MMSE \< 19 points) (MMSE is specifically chosen here to avoid too frequent repetitions of the MoCA, which is used as an outcome parameter for the interventional trial)
* physical inability to perform exercise training or other trainings as judged by a physician
* manifest (severe) depression (Beck Depression Inventory, BDI-II \> 29 points)
* participation in other interventional trials
* other significant diseases of the central nervous system
* Planned change in medication within the following 6 months

Where it's running

  • University Hospital of Schleswig Holstein Campus Kiel
    Kiel, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.